Menu

A panel of three U.S. Court of Appeals for the D.C. Circuit judges heard oral arguments Monday in a case centered around drugmakers' efforts to implement 340B rebate models.

News Alert

D.C. Circuit Holds 340B Rebate Oral Arguments; HRSA Approves Novartis’ Rebate Plan with Delayed Start

November 17, 2025 William Newton and Shannon Young, Associate Editor/Senior Writer 340B Report Views

A three-judge Washington D.C. federal appeals court panel pressed drug industry, Trump administration and hospital lawyers Monday on their contrasting [...]

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.

Please be sure you’ve completed your one-minute subscription completion form.
I have read and accepted the terms of use and privacy policy.
Log In!

If you are not yet a paid subscriber, please Subscribe now

For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.

William Newton and Shannon Young

A Guide to Monday’s High-Stakes Federal Appeals Court Hearing on Drugmaker 340B Rebates

Bluesight